CAM
Close Asset Management Portfolio holdings
AUM
$3.42B
1-Year Return
20.4%
This Quarter Return
+18.85%
1 Year Return
+20.4%
3 Year Return
+78.01%
5 Year Return
+124.39%
10 Year Return
–
AUM
$1.17B
AUM Growth
+$271M
(+30%)
Cap. Flow
+$439M
Cap. Flow
% of AUM
37.35%
Top 10 Holdings %
Top 10 Hldgs %
76.28%
Holding
211
New
23
Increased
90
Reduced
90
Closed
8
Top Buys
| 1 |
Visa
V
|
$153M |
| 2 |
Microsoft
MSFT
|
$133M |
| 3 |
Adobe
ADBE
|
$121M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$108M |
| 5 |
CELG
Celgene Corp
CELG
|
$96.2M |
Top Sells
| 1 |
American Express
AXP
|
$108M |
| 2 |
Neurocrine Biosciences
NBIX
|
$93.1M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
$69M |
| 4 |
Procter & Gamble
PG
|
$61.3M |
| 5 |
Canadian Imperial Bank of Commerce
CM
|
$32.7M |
Sector Composition
| 1 | Technology | 33.95% |
| 2 | Healthcare | 22.86% |
| 3 | Financials | 17.86% |
| 4 | Communication Services | 13.23% |
| 5 | Consumer Discretionary | 4.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLVS
126
DELISTED
Clovis Oncology, Inc.
CLVS
| $59K | 0.01% |
2,375
+300
| +14% | +$7.45K |
|
127
Southwest Airlines
LUV
$16.3B
| $57K | ﹤0.01% |
1,100
-49,566
| -98% | -$2.57M |
|
128
Cigna
CI
$81.2B
| $55K | ﹤0.01% |
+342
| New | +$55K |
|
129
Vanguard FTSE Pacific ETF
VPL
$7.75B
| $55K | ﹤0.01% |
840
-185
| -18% | -$12.1K |
|
130
Costco
COST
$424B
| $53K | ﹤0.01% |
220
-15,645
| -99% | -$3.77M |
|
131
Qualcomm
QCOM
$172B
| $51K | ﹤0.01% |
900
-1,450
| -62% | -$82.2K |
|
132
DNOW Inc
DNOW
$1.68B
| $49K | ﹤0.01% |
3,496
-98,443
| -97% | -$1.38M |
|
|
PETQ
133
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $47K | ﹤0.01% |
1,500
-230
| -13% | -$7.21K |
|
134
Newmont
NEM
$82.3B
| $43K | ﹤0.01% |
1,200
-25,780
| -96% | -$924K |
|
135
iShares Global Healthcare ETF
IXJ
$3.83B
| $41K | ﹤0.01% |
672
-7,728
| -92% | -$472K |
|
136
Resideo Technologies
REZI
$5.23B
| $41K | ﹤0.01% |
+2,123
| New | +$41K |
|
137
Archer Daniels Midland
ADM
$29.8B
| $39K | ﹤0.01% |
900
-1,200
| -57% | -$52K |
|
138
Gold Fields
GFI
$29.9B
| $39K | ﹤0.01% |
10,350
+8,038
| +348% | +$30.3K |
|
139
Bristol-Myers Squibb
BMY
$95B
| $37K | ﹤0.01% |
+768
| New | +$37K |
|
140
CME Group
CME
$96.4B
| $34K | ﹤0.01% |
+206
| New | +$34K |
|
141
Wheaton Precious Metals
WPM
$46.6B
| $33K | ﹤0.01% |
1,390
-21,783
| -94% | -$517K |
|
142
Revvity
RVTY
$9.95B
| $29K | ﹤0.01% |
300
+50
| +20% | +$4.83K |
|
143
Chemours
CC
$2.26B
| $27K | ﹤0.01% |
722
-22,094
| -97% | -$826K |
|
144
Oramed Pharmaceuticals
ORMP
$91M
| $27K | ﹤0.01% |
7,500
+7,300
| +3,650% | +$26.3K |
|
145
Wynn Resorts
WYNN
$12.8B
| $27K | ﹤0.01% |
225
-325
| -59% | -$39K |
|
146
Hewlett Packard
HPE
$30.5B
| $26K | ﹤0.01% |
1,700
-452,728
| -100% | -$6.92M |
|
147
HP
HPQ
$27B
| $24K | ﹤0.01% |
1,250
+1,090
| +681% | +$20.9K |
|
|
148
Neurocrine Biosciences
NBIX
$13.9B
| $24K | ﹤0.01% |
268
-1,039,174
| -100% | -$93.1M |
|
|
AVDL
149
Avadel Pharmaceuticals
AVDL
$1.46B
| $22K | ﹤0.01% |
15,000
+14,838
| +9,159% | +$21.8K |
|
150
iShares MSCI KLD 400 Social ETF
DSI
$4.83B
| $22K | ﹤0.01% |
424
+224
| +112% | +$11.6K |
|